Store your medication only as directed
Several GLP-1RAs reduce circulating C-reactive protein (CRP) levels, supporting the hypothesis that reduced inflammation plays a key role in the ASCVD benefit profile of this drug class (52, 59)
Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y
The comprehensive exploration of their benefits underscores their transformative potential in medicine, positioning them as a promising approach for addressing a wide array of health issues and paving the way for new research and clinical applications
The NovoCare Patient Assistance Program (PAP) helps low-income individuals who are uninsured or underinsured and cannot afford their medications
GLP-1 companion formulas are designed to support people on medication, not replace the medication itself